Anita Grigoriadis

33PUBLICATIONS
219CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 13, 2026
CD1d remodels the tumor-infiltrating myeloid populations controlling antitumor immunity.

|Mar 12, 2026
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors.

Callum Walker, Gabriel Kollarovic, Daniel Weekes

|Mar 06, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Winnie Fernando, Jarama Clucas, Alberto Rizzo

|Oct 24, 2025
Issues and missed opportunities in lymph node assessment after neoadjuvant chemotherapy.

Lucy Ryan, Elena Provenzano, Anita Grigoriadis

|Oct 23, 2025
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.

Alicia M Chenoweth, Anthony Cheung, Jitesh Chauhan

|Dec 12, 2024
CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.

James T Paget, Joseph A Ward, Andrew R McKean

Pageof 6

Frequent Collaborators

10 joint publications

Andrew Tutt

5 joint publications

Sarah Pinder

5 joint publications

Sophia N Karagiannis

5 joint publications

Syed Haider